These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25118703)

  • 1. Recent progress in multidrug delivery to cancer cells by liposomes.
    Mo R; Jiang T; Gu Z
    Nanomedicine (Lond); 2014; 9(8):1117-20. PubMed ID: 25118703
    [No Abstract]   [Full Text] [Related]  

  • 2. Surface-active liposomes for targeted cancer therapy.
    Sofou S
    Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug and gene co-delivery systems for cancer treatment.
    Yang Z; Gao D; Cao Z; Zhang C; Cheng D; Liu J; Shuai X
    Biomater Sci; 2015 Jul; 3(7):1035-49. PubMed ID: 26221938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of novel drug delivery system, fusogenic liposome, for cancer therapy].
    Kunisawa J; Mayumi T
    Gan To Kagaku Ryoho; 2001 May; 28(5):577-83. PubMed ID: 11383204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research progress in co-delivery of gene and chemotherapy drugs with cationic liposome carrier for cancer therapy].
    Chen WG; Liu YG; Wang SB; Chen AZ
    Yao Xue Xue Bao; 2012 Aug; 47(8):986-92. PubMed ID: 23162893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-sensitive liposomes for drug delivery in cancer treatment.
    Ferreira Ddos S; Lopes SC; Franco MS; Oliveira MC
    Ther Deliv; 2013 Sep; 4(9):1099-123. PubMed ID: 24024511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug delivery in cancer using liposomes.
    Dass CR
    Methods Mol Biol; 2008; 437():177-82. PubMed ID: 18369969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
    Malam Y; Loizidou M; Seifalian AM
    Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liposome-mediated gene delivery].
    Kaneda Y
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1806-13. PubMed ID: 9279116
    [No Abstract]   [Full Text] [Related]  

  • 10. Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool.
    Kaneda Y
    Expert Opin Drug Deliv; 2010 Sep; 7(9):1079-93. PubMed ID: 20716020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success.
    Muthu MS; Feng SS
    Expert Opin Drug Deliv; 2013 Feb; 10(2):151-5. PubMed ID: 23061654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal drug delivery systems--clinical applications.
    Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
    Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second generation liposomal cancer therapeutics: transition from laboratory to clinic.
    Sen K; Mandal M
    Int J Pharm; 2013 May; 448(1):28-43. PubMed ID: 23500602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-targeted liposomes for cancer treatment.
    Sapra P; Tyagi P; Allen TM
    Curr Drug Deliv; 2005 Oct; 2(4):369-81. PubMed ID: 16305440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomes as targeted drug delivery systems in the treatment of breast cancer.
    Sharma G; Anabousi S; Ehrhardt C; Ravi Kumar MN
    J Drug Target; 2006 Jun; 14(5):301-10. PubMed ID: 16882550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trastuzumab-conjugated boron-containing liposomes for tumor-cell targeting; development and cellular studies.
    Wei Q; Kullberg EB; Gedda L
    Int J Oncol; 2003 Oct; 23(4):1159-65. PubMed ID: 12963999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonodynamic therapy (SDT): a novel treatment of cancer based on sonosensitizer liposome as a new drug carrier.
    Dai ZJ; Li S; Gao J; Xu XN; Lu WF; Lin S; Wang XJ
    Med Hypotheses; 2013 Mar; 80(3):300-2. PubMed ID: 23294609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer cell specific gene delivery by laminin-derived peptide AG73-labeled liposomes.
    Iijima H; Negishi Y; Omata D; Nomizu M; Aramaki Y
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4712-4. PubMed ID: 20615691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sterically stabilized liposomes in cancer therapy and gene delivery.
    Lasic DD; Vallner JJ; Working PK
    Curr Opin Mol Ther; 1999 Apr; 1(2):177-85. PubMed ID: 11715941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.